1. Bonomi P, Modiano M, Cornett P, Koehler M, Schiller J (2001) Phase II trial to assess the activity of ZD0473 in patients with small cell lung cancer who have failed one prior platinum chemotherapy regimen. Proc ASCO 20: Abstract 1284
2. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41
3. Drug Data File, CR UK, Phase I/II Committee 1997
4. Gore ME, Atkinson RJ, Dirix L, Rischin D, Beale PJ, Harnet P, Hacking D, Cure H, Coseart J, Pemberton K, Hoctin-Boes G (2002) ZD0473 phase II monotherapy trial in second line ovarian cancer. Proc ASCO 21: Abstract 881
5. Holford J, Raynaud F, Murrer BA, Grimaldi K, Hartley J, Abrams M, Kelland LR (1998a) Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum (II) (AMD473). Anti-Cancer Drug Design 13: 1–18